Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Integrated Trans-omics Approach to Diabetic Cardio-renal Complications: From Novel Discoveries to Personalized Medicine Substudy 2: The Hong Kong Diabetes Biobank

NCT05282680 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT05282680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05282680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Integrated Trans-omics Approach to Diabetic Cardio-renal Complications: From Novel Discoveries to Personalized Medicine Substudy 2: The Hong Kong Diabetes Biobank
Lead sponsor
Chinese University of Hong Kong
Phase
Observational
Overall status
Active, not recruiting
Start date
February 1, 2014
Completion date
December 31, 2063
Enrollment
48,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, coronary heart disease, diabetes, diabetes mellitus, diabetic angiopathies, diabetic kidney disease, diabetic nephropathies, diabetic retinopathy, stroke, type 1 diabetes, type 2 diabetes